SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5sy5'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AKD_A_CAMA420_0 (CYTOCHROME P450CAM)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR (Mus musculus)	5 / 11	LEU A 225 VAL A 179 GLY A 184 THR A 208 VAL A 213	None	1.13A	1akdA-5sy5A: undetectable	1akdA-5sy5A: 21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AKD_A_CAMA420_0 (CYTOCHROME P450CAM)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR (Mus musculus)	5 / 11	PHE A 263 VAL A 179 GLY A 184 THR A 208 VAL A 213	None	1.13A	1akdA-5sy5A: undetectable	1akdA-5sy5A: 21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AQB_A_RTLA185_0 (RETINOL-BINDING PROTEIN)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus; Mus musculus)	5 / 10	ALA A 172 VAL B 182 LEU B 198 HIS B 289 PHE B 149	None	1.34A	1aqbA-5sy5A: undetectable	1aqbA-5sy5A: 20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ERR_A_RALA600_1 (ESTROGEN RECEPTOR)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	5 / 12	ALA B 152 TRP B 108 LEU B 287 ILE B 142 LEU A 159	None	1.19A	1errA-5sy5B: undetectable	1errA-5sy5B: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NT6_A_DVAA8_0 (GRAMICIDIN C)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 5	GLY B 345 VAL B 343 TRP B 371 TRP B 380	None	1.46A	1nt6A-5sy5B: undetectable	1nt6A-5sy5B: 3.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NT6_B_DVAB8_0 (GRAMICIDIN C)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 5	GLY B 345 VAL B 343 TRP B 371 TRP B 380	None	1.46A	1nt6B-5sy5B: undetectable	1nt6B-5sy5B: 3.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PHG_A_MYTA422_1 (CYTOCHROME P450-CAM)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR (Mus musculus)	5 / 11	LEU A 225 VAL A 179 GLY A 184 THR A 208 VAL A 213	None	1.08A	1phgA-5sy5A: undetectable	1phgA-5sy5A: 21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PHG_A_MYTA422_1 (CYTOCHROME P450-CAM)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR (Mus musculus)	5 / 11	PHE A 263 VAL A 179 GLY A 184 THR A 208 VAL A 213	None	1.09A	1phgA-5sy5A: undetectable	1phgA-5sy5A: 21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RTS_A_D16A309_1 (THYMIDYLATE SYNTHASE)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 8	ILE B 271 ASP B 147 GLY B 148 PHE B 149	None	0.78A	1rtsA-5sy5B: undetectable	1rtsA-5sy5B: 20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RTS_B_D16B409_1 (THYMIDYLATE SYNTHASE)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 7	ILE B 271 ASP B 147 GLY B 148 PHE B 149	None	0.86A	1rtsB-5sy5B: undetectable	1rtsB-5sy5B: 20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WSV_A_THHA3001_1 (AMINOMETHYLTRANSFERA SE)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus; Mus musculus)	3 / 3	ASP A 161 GLU B 164 TYR B 94	None	0.84A	1wsvA-5sy5A: undetectable	1wsvA-5sy5A: 21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2TSR_A_D16A309_1 (THYMIDYLATE SYNTHASE)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 7	ILE B 271 ASP B 147 GLY B 148 PHE B 149	None	0.83A	2tsrA-5sy5B: undetectable	2tsrA-5sy5B: 20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX1_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 8	PHE B 159 GLU B 176 SER B 173 VAL B 166	None	1.06A	3jx1A-5sy5B: undetectable 3jx1B-5sy5B: undetectable	3jx1A-5sy5B: 20.44 3jx1B-5sy5B: 20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_K_TFPK201_1 (PROTEIN S100-A4)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 8	GLY B 140 ILE A 178 CYH A 336 PHE A 335	None	0.97A	3ko0K-5sy5B: undetectable 3ko0S-5sy5B: undetectable	3ko0K-5sy5B: 14.73 3ko0S-5sy5B: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RV5_D_DXCD92_0 (TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 5	VAL B 365 GLU B 298 LYS B 269 PHE B 249	None	1.19A	3rv5C-5sy5B: undetectable 3rv5D-5sy5B: undetectable	3rv5C-5sy5B: 12.63 3rv5D-5sy5B: 12.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9F_D_CLMD221_0 (CHLORAMPHENICOL ACETYLTRANSFERASE)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	5 / 12	THR B 315 SER B 338 TYR B 340 SER B 311 VAL B 399	None	1.34A	3u9fD-5sy5B: undetectable 3u9fE-5sy5B: undetectable	3u9fD-5sy5B: 17.78 3u9fE-5sy5B: 17.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9F_O_CLMO221_0 (CHLORAMPHENICOL ACETYLTRANSFERASE)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	5 / 11	THR B 315 SER B 338 TYR B 340 SER B 311 VAL B 399	None	1.37A	3u9fM-5sy5B: undetectable 3u9fO-5sy5B: undetectable	3u9fM-5sy5B: 17.78 3u9fO-5sy5B: 17.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W67_C_VIVC301_0 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	5 / 12	LEU B 356 ALA B 385 ILE B 351 LEU B 314 VAL B 399	None	1.16A	3w67C-5sy5B: undetectable	3w67C-5sy5B: 19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W68_B_VIVB301_0 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	5 / 12	LEU B 356 VAL B 387 ILE B 351 LEU B 314 VAL B 399	None	1.01A	3w68B-5sy5B: undetectable	3w68B-5sy5B: 19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E3H_A_HQEA303_1 (CARBONIC ANHYDRASE 2)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR (Mus musculus)	5 / 10	PHE A 263 VAL A 218 LEU A 209 THR A 208 VAL A 213	None	0.95A	4e3hA-5sy5A: undetectable	4e3hA-5sy5A: 19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HXY_B_ACAB502_1 (PLM1)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 7	VAL B 343 SER B 383 TYR B 369 LEU B 314	None	0.95A	4hxyB-5sy5B: undetectable	4hxyB-5sy5B: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IQQ_B_D16B402_1 (THYMIDYLATE SYNTHASE)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 7	ILE B 271 ASP B 147 GLY B 148 PHE B 149	None	0.79A	4iqqB-5sy5B: undetectable	4iqqB-5sy5B: 21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IQQ_C_D16C402_1 (THYMIDYLATE SYNTHASE)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 7	ILE B 271 ASP B 147 GLY B 148 PHE B 149	None	0.83A	4iqqC-5sy5B: undetectable	4iqqC-5sy5B: 21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OLM_A_198A1001_1 (ANDROGEN RECEPTOR)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	5 / 12	LEU A 343 GLY A 174 LEU B 146 HIS B 289 THR B 274	None	1.12A	4olmA-5sy5A: undetectable	4olmA-5sy5A: 21.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ZPH_A_PRLA501_0 (ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus; Mus musculus)	6 / 7	ARG A 266 VAL A 305 TRP B 380 LEU B 406 SER B 407 GLU B 410	None	0.64A	4zphA-5sy5A: 10.7 4zphB-5sy5A: 11.0	4zphA-5sy5A: 100.00 4zphB-5sy5A: 28.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5C0O_G_SAMG301_1 (TRNA (ADENINE(58)-N(1))-M ETHYLTRANSFERASE TRMI)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus; Mus musculus)	3 / 3	GLU A 223 HIS B 302 ASP A 217	None	0.81A	5c0oG-5sy5A: undetectable	5c0oG-5sy5A: 20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5F9Z_B_HFGB703_0 (AMINOACYL-TRNA SYNTHETASE)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus; Mus musculus)	5 / 12	LEU A 408 PHE A 427 VAL A 425 PHE A 363 GLY B 345	None	1.17A	5f9zB-5sy5A: undetectable	5f9zB-5sy5A: 21.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HS6_A_J3ZA302_1 (17-BETA-HYDROXYSTERO ID DEHYDROGENASE 14)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 8	HIS B 272 GLN A 344 LEU B 291 THR A 309	None	1.08A	5hs6A-5sy5B: undetectable	5hs6A-5sy5B: 24.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NOO_A_D16A402_1 (THYMIDYLATE SYNTHASE)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 7	ILE B 271 ASP B 147 GLY B 148 PHE B 149	None	0.78A	5nooA-5sy5B: undetectable	5nooA-5sy5B: 21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NOO_B_D16B402_1 (THYMIDYLATE SYNTHASE)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 7	ILE B 271 ASP B 147 GLY B 148 PHE B 149	None	0.85A	5nooB-5sy5B: undetectable	5nooB-5sy5B: 21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X5Q_C_D16C402_1 (THYMIDYLATE SYNTHASE)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 7	ILE B 271 ASP B 147 GLY B 148 PHE B 149	None	0.83A	5x5qC-5sy5B: undetectable	5x5qC-5sy5B: 20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X5Q_D_D16D402_1 (THYMIDYLATE SYNTHASE)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 8	ILE B 271 ASP B 147 GLY B 148 PHE B 149	None	0.81A	5x5qD-5sy5B: undetectable	5x5qD-5sy5B: 20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X5Q_F_D16F402_1 (THYMIDYLATE SYNTHASE)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 8	ILE B 271 ASP B 147 GLY B 148 PHE B 149	None	0.81A	5x5qF-5sy5B: undetectable	5x5qF-5sy5B: 20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B58_A_ACTA606_0 (FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR (Mus musculus)	4 / 5	GLU A 362 PHE A 363 ASP A 377 THR A 383	None	1.33A	6b58A-5sy5A: undetectable	6b58A-5sy5A: 21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 7	ARG B 99 ARG B 98 LEU B 97 ALA B 152	None	1.19A	6b89A-5sy5B: undetectable	6b89A-5sy5B: 14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BXM_A_SAMA402_0 (DIPHTHAMIDE BIOSYNTHESIS ENZYME DPH2)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus; Mus musculus)	5 / 12	LEU B 172 SER A 157 GLN B 174 LEU B 72 ILE B 78	None	1.20A	6bxmA-5sy5B: undetectable	6bxmA-5sy5B: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C2M_A_SUEA1202_1 (NS3 PROTEASE)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR (Mus musculus)	5 / 9	VAL A 304 HIS A 302 ARG A 266 VAL A 218 ASP A 217	None	1.37A	6c2mA-5sy5A: undetectable	6c2mA-5sy5A: 13.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C2M_C_SUEC1203_1 (NS3 PROTEASE)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR (Mus musculus)	5 / 9	VAL A 304 HIS A 302 LEU A 209 ARG A 266 ASP A 217	None	1.37A	6c2mC-5sy5A: undetectable	6c2mC-5sy5A: 13.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_F_TA1F502_2 (TUBULIN BETA CHAIN)	5sy5	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 5	LEU A 167 LEU B 143 THR A 160 PRO B 75	None	1.10A	6ew0F-5sy5A: undetectable	6ew0F-5sy5A: 10.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HZP_A_FVTA501_0 (PEPTIDE ABC TRANSPORTER PERMEASE)	5sy5	NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1 (Mus musculus)	4 / 8	VAL B 92 GLN B 155 ASN B 154 GLU B 156	None	0.77A	6hzpA-5sy5B: undetectable	6hzpA-5sy5B: 22.35

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AKD_A_CAMA420_0","CYTOCHROME P450CAM","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR","Mus musculus",5,"LEU A 225;VAL A 179;GLY A 184;THR A 208;VAL A 213","None","1.13A","1akdA-5sy5A:undetectable","1akdA-5sy5A:21.71"],["1AKD_A_CAMA420_0","CYTOCHROME P450CAM","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR","Mus musculus",5,"PHE A 263;VAL A 179;GLY A 184;THR A 208;VAL A 213","None","1.13A","1akdA-5sy5A:undetectable","1akdA-5sy5A:21.71"],["1AQB_A_RTLA185_0","RETINOL-BINDING PROTEIN","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR;NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus;Mus musculus",5,"ALA A 172;VAL B 182;LEU B 198;HIS B 289;PHE B 149","None","1.34A","1aqbA-5sy5A:undetectable","1aqbA-5sy5A:20.58"],["1ERR_A_RALA600_1","ESTROGEN RECEPTOR","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR;NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",5,"ALA B 152;TRP B 108;LEU B 287;ILE B 142;LEU A 159","None","1.19A","1errA-5sy5B:undetectable","1errA-5sy5B:20.73"],["1NT6_A_DVAA8_0","GRAMICIDIN C","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"GLY B 345;VAL B 343;TRP B 371;TRP B 380","None","1.46A","1nt6A-5sy5B:undetectable","1nt6A-5sy5B:3.62"],["1NT6_B_DVAB8_0","GRAMICIDIN C","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"GLY B 345;VAL B 343;TRP B 371;TRP B 380","None","1.46A","1nt6B-5sy5B:undetectable","1nt6B-5sy5B:3.62"],["1PHG_A_MYTA422_1","CYTOCHROME P450-CAM","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR","Mus musculus",5,"LEU A 225;VAL A 179;GLY A 184;THR A 208;VAL A 213","None","1.08A","1phgA-5sy5A:undetectable","1phgA-5sy5A:21.71"],["1PHG_A_MYTA422_1","CYTOCHROME P450-CAM","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR","Mus musculus",5,"PHE A 263;VAL A 179;GLY A 184;THR A 208;VAL A 213","None","1.09A","1phgA-5sy5A:undetectable","1phgA-5sy5A:21.71"],["1RTS_A_D16A309_1","THYMIDYLATE SYNTHASE","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"ILE B 271;ASP B 147;GLY B 148;PHE B 149","None","0.78A","1rtsA-5sy5B:undetectable","1rtsA-5sy5B:20.81"],["1RTS_B_D16B409_1","THYMIDYLATE SYNTHASE","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"ILE B 271;ASP B 147;GLY B 148;PHE B 149","None","0.86A","1rtsB-5sy5B:undetectable","1rtsB-5sy5B:20.81"],["1WSV_A_THHA3001_1","AMINOMETHYLTRANSFERASE","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR;NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus;Mus musculus",3,"ASP A 161;GLU B 164;TYR B  94","None","0.84A","1wsvA-5sy5A:undetectable","1wsvA-5sy5A:21.96"],["2TSR_A_D16A309_1","THYMIDYLATE SYNTHASE","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"ILE B 271;ASP B 147;GLY B 148;PHE B 149","None","0.83A","2tsrA-5sy5B:undetectable","2tsrA-5sy5B:20.81"],["3JX1_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"PHE B 159;GLU B 176;SER B 173;VAL B 166","None","1.06A","3jx1A-5sy5B:undetectable;3jx1B-5sy5B:undetectable","3jx1A-5sy5B:20.44;3jx1B-5sy5B:20.44"],["3KO0_K_TFPK201_1","PROTEIN S100-A4;PROTEIN S100-A4","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR;NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"GLY B 140;ILE A 178;CYH A 336;PHE A 335","None","0.97A","3ko0K-5sy5B:undetectable;3ko0S-5sy5B:undetectable","3ko0K-5sy5B:14.73;3ko0S-5sy5B:14.73"],["3RV5_D_DXCD92_0","TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"VAL B 365;GLU B 298;LYS B 269;PHE B 249","None","1.19A","3rv5C-5sy5B:undetectable;3rv5D-5sy5B:undetectable","3rv5C-5sy5B:12.63;3rv5D-5sy5B:12.63"],["3U9F_D_CLMD221_0","CHLORAMPHENICOL ACETYLTRANSFERASE","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",5,"THR B 315;SER B 338;TYR B 340;SER B 311;VAL B 399","None","1.34A","3u9fD-5sy5B:undetectable;3u9fE-5sy5B:undetectable","3u9fD-5sy5B:17.78;3u9fE-5sy5B:17.78"],["3U9F_O_CLMO221_0","CHLORAMPHENICOL ACETYLTRANSFERASE","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",5,"THR B 315;SER B 338;TYR B 340;SER B 311;VAL B 399","None","1.37A","3u9fM-5sy5B:undetectable;3u9fO-5sy5B:undetectable","3u9fM-5sy5B:17.78;3u9fO-5sy5B:17.78"],["3W67_C_VIVC301_0","ALPHA-TOCOPHEROL TRANSFER PROTEIN","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",5,"LEU B 356;ALA B 385;ILE B 351;LEU B 314;VAL B 399","None","1.16A","3w67C-5sy5B:undetectable","3w67C-5sy5B:19.90"],["3W68_B_VIVB301_0","ALPHA-TOCOPHEROL TRANSFER PROTEIN","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",5,"LEU B 356;VAL B 387;ILE B 351;LEU B 314;VAL B 399","None","1.01A","3w68B-5sy5B:undetectable","3w68B-5sy5B:19.90"],["4E3H_A_HQEA303_1","CARBONIC ANHYDRASE 2","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR","Mus musculus",5,"PHE A 263;VAL A 218;LEU A 209;THR A 208;VAL A 213","None","0.95A","4e3hA-5sy5A:undetectable","4e3hA-5sy5A:19.84"],["4HXY_B_ACAB502_1","PLM1","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"VAL B 343;SER B 383;TYR B 369;LEU B 314","None","0.95A","4hxyB-5sy5B:undetectable","4hxyB-5sy5B:21.13"],["4IQQ_B_D16B402_1","THYMIDYLATE SYNTHASE","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"ILE B 271;ASP B 147;GLY B 148;PHE B 149","None","0.79A","4iqqB-5sy5B:undetectable","4iqqB-5sy5B:21.04"],["4IQQ_C_D16C402_1","THYMIDYLATE SYNTHASE","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"ILE B 271;ASP B 147;GLY B 148;PHE B 149","None","0.83A","4iqqC-5sy5B:undetectable","4iqqC-5sy5B:21.04"],["4OLM_A_198A1001_1","ANDROGEN RECEPTOR","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR;NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",5,"LEU A 343;GLY A 174;LEU B 146;HIS B 289;THR B 274","None","1.12A","4olmA-5sy5A:undetectable","4olmA-5sy5A:21.03"],["4ZPH_A_PRLA501_0","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR;ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR;NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus;Mus musculus",6,"ARG A 266;VAL A 305;TRP B 380;LEU B 406;SER B 407;GLU B 410","None","0.64A","4zphA-5sy5A:10.7;4zphB-5sy5A:11.0","4zphA-5sy5A:100.00;4zphB-5sy5A:28.54"],["5C0O_G_SAMG301_1","TRNA (ADENINE(58)-N(1))-METHYLTRANSFERASE TRMI","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR;NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus;Mus musculus",3,"GLU A 223;HIS B 302;ASP A 217","None","0.81A","5c0oG-5sy5A:undetectable","5c0oG-5sy5A:20.49"],["5F9Z_B_HFGB703_0","AMINOACYL-TRNA SYNTHETASE","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR;NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus;Mus musculus",5,"LEU A 408;PHE A 427;VAL A 425;PHE A 363;GLY B 345","None","1.17A","5f9zB-5sy5A:undetectable","5f9zB-5sy5A:21.68"],["5HS6_A_J3ZA302_1","17-BETA-HYDROXYSTEROID DEHYDROGENASE 14","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR;NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"HIS B 272;GLN A 344;LEU B 291;THR A 309","None","1.08A","5hs6A-5sy5B:undetectable","5hs6A-5sy5B:24.38"],["5NOO_A_D16A402_1","THYMIDYLATE SYNTHASE","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"ILE B 271;ASP B 147;GLY B 148;PHE B 149","None","0.78A","5nooA-5sy5B:undetectable","5nooA-5sy5B:21.04"],["5NOO_B_D16B402_1","THYMIDYLATE SYNTHASE","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"ILE B 271;ASP B 147;GLY B 148;PHE B 149","None","0.85A","5nooB-5sy5B:undetectable","5nooB-5sy5B:21.04"],["5X5Q_C_D16C402_1","THYMIDYLATE SYNTHASE","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"ILE B 271;ASP B 147;GLY B 148;PHE B 149","None","0.83A","5x5qC-5sy5B:undetectable","5x5qC-5sy5B:20.32"],["5X5Q_D_D16D402_1","THYMIDYLATE SYNTHASE","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"ILE B 271;ASP B 147;GLY B 148;PHE B 149","None","0.81A","5x5qD-5sy5B:undetectable","5x5qD-5sy5B:20.32"],["5X5Q_F_D16F402_1","THYMIDYLATE SYNTHASE","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"ILE B 271;ASP B 147;GLY B 148;PHE B 149","None","0.81A","5x5qF-5sy5B:undetectable","5x5qF-5sy5B:20.32"],["6B58_A_ACTA606_0","FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR","Mus musculus",4,"GLU A 362;PHE A 363;ASP A 377;THR A 383","None","1.33A","6b58A-5sy5A:undetectable","6b58A-5sy5A:21.28"],["6B89_B_NOVB403_1","LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB;LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"ARG B  99;ARG B  98;LEU B  97;ALA B 152","None","1.19A","6b89A-5sy5B:undetectable","6b89A-5sy5B:14.08"],["6BXM_A_SAMA402_0","DIPHTHAMIDE BIOSYNTHESIS ENZYME DPH2","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR;NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus;Mus musculus",5,"LEU B 172;SER A 157;GLN B 174;LEU B  72;ILE B  78","None","1.20A","6bxmA-5sy5B:undetectable","6bxmA-5sy5B:21.18"],["6C2M_A_SUEA1202_1","NS3 PROTEASE","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR","Mus musculus",5,"VAL A 304;HIS A 302;ARG A 266;VAL A 218;ASP A 217","None","1.37A","6c2mA-5sy5A:undetectable","6c2mA-5sy5A:13.84"],["6C2M_C_SUEC1203_1","NS3 PROTEASE","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR","Mus musculus",5,"VAL A 304;HIS A 302;LEU A 209;ARG A 266;ASP A 217","None","1.37A","6c2mC-5sy5A:undetectable","6c2mC-5sy5A:13.84"],["6EW0_F_TA1F502_2","TUBULIN BETA CHAIN","5sy5","ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR;NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"LEU A 167;LEU B 143;THR A 160;PRO B  75","None","1.10A","6ew0F-5sy5A:undetectable","6ew0F-5sy5A:10.84"],["6HZP_A_FVTA501_0","PEPTIDE ABC TRANSPORTER PERMEASE","5sy5","NEURONAL PAS DOMAIN-CONTAINING PROTEIN 1","Mus musculus",4,"VAL B  92;GLN B 155;ASN B 154;GLU B 156","None","0.77A","6hzpA-5sy5B:undetectable","6hzpA-5sy5B:22.35"]]